MIF has been recognized as a risk factor for sudden cardiac death in patients with HHD, hypertrophic cardiomyopathy, and non-ischemic dilated cardiomyopathy (Bockstall and Link, 2012; Gulati et al., 2013; Shenasa and Shenasa, 2017). This evidence concerns the gene MIF and hypertrophic cardiomyopathy.